The ASHP Board of Directors Award of Honor recognizes individuals outside the pharmacy discipline who have made extraordinary national or worldwide contributions to the health field.
An internationally acclaimed leader and scientist, Dr. Dzau is a strong advocate for the engagement of pharmacists on the interprofessional healthcare team as well their participation in critical public health initiatives. He is the Chair of the NAM Action Collaborative on Clinician Well-Being and Resilience, of which ASHP is an original sponsor, and has led initiatives such as the Commission on a Global Health Risk Framework for the Future, the Human Genome Editing Initiative, and Vital Directions for Health and Health Care. Dr. Dzau’s seminal work in cardiovascular medicine and genetics laid the foundation for the development of ACE inhibitors. He also pioneered gene therapy for vascular disease and was the first to introduce DNA decoy molecules to block transcriptions in humans in vivo.
ASHP Board of Directors Distinguished Leadership Award
Recipient: John A. Armitstead, M.S., R.Ph., FASHP
System Director of Pharmacy Services, Lee Health, Fort Myers, Fla.
The Board of Directors Distinguished Leadership Award recognizes contributions to excellence in pharmacy practice leadership in acute and ambulatory care settings.
Mr. Armitstead is an engaging and respected pharmacy administrator and leader. His contributions to ASHP and the profession have elevated pharmacy practice in countless ways, including his support for continuous professional development for the pharmacy workforce. In his nine years at Lee Health, he expanded the pharmacy enterprise, adding more than 140 new pharmacy practice positions under approved, innovative business plans. Active in national and state pharmacy associations for more than three decades, Mr. Armitstead is a Past President of ASHP, the Ohio Society of Health-System Pharmacists (OSHP), and the Kentucky Society of Health-System Pharmacists (KSHP). He also served terms on the Board of Directors of ASHP, OSHP, and KSHP and was Chair of the House of Delegates of the Florida Society of Health-System Pharmacists.
ASHP Board of Directors Donald E. Francke Medal
Recipient: Anthony Serracino-Inglott, Pharm.D.
Professor, Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta, Msida.
The ASHP Board of Directors Donald E. Francke Medal honors pharmacists who have made significant international contributions to advance pharmacy practice.
Inspired by the example of Donald Francke, a founding member of ASHP and a visionary for ASHP's practice standards, guidelines, education, and publications, Dr. Serracino-Inglott was instrumental in developing clinical pharmacy services and establishing hospital interprofessional practices and collaborative healthcare higher education models in Europe. He is active in pharmaceutical regulatory sciences leading to international collaboration in promoting the safety, efficacy, and quality of medicines. He is Chair of the Malta Medicines Authority and a member of the Management Board of the European Medicines Agency.
ASHP–Association of Black Health-System Pharmacists Joint Leadership Award
Recipient: Kathleen B. Kennedy, Pharm.D.
Professor and Dean, Xavier University of Louisiana College of Pharmacy, New Orleans.
The ASHP-ABHP Joint Leadership Award recognizes individuals who have demonstrated exceptional leadership in efforts to reduce racial and ethnic disparities in healthcare.
Dr. Kennedy is a national champion of health equity and a passionate advocate for reducing racial and ethnic disparities in healthcare. A respected leader, educator, and researcher, she has leveraged her expertise in the areas of cultural competence and community engagement throughout her career to create a more just and inclusive healthcare system that improves, advances, and transforms healthcare for all patients and ensures all members of our communities receive optimal care.